Work

A Phase 2a, Open-Label, Dose-Finding Study To Determine The Safety and Tolerability Of Sotatercept (ACE-011) In Adults With Beta (β)-Thalassemia: Interim Results

Year: 2013

Type: article

Source: Blood

DOI: 10.1182/blood.v122.21.3448.3448

Authors: Maria-Domenica Cappellini, John Porter, Raffaella Origa, Gian Luca Forni, Adberrahmane Laadem, Frédéric Galacteros, Dimana Miteva, Victoria Sung, Rajesh Chopra, Jean-Benoît Arlet, Jean-Antoine Ribeil, Kenneth Klesczewski, Kenneth Attie, Maciej Garbowski, Olivier Hermine

Institutions: University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University College London, University of Cagliari, Ospedale Microcitemico, Ente Ospedaliero Ospedali Galliera, Celgene (United States), Centre Hospitalier Universitaire Henri-Mondor, Hôpitaux Universitaires Henri-Mondor, Hôpital Necker-Enfants Malades, Institut des Maladies Génétiques Imagine, Acceleron Pharma (United States)

Language: English

Topic: Hemoglobinopathies and Related Disorders

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1344043

FWCI: 1.147

Cites:

Cited by: 15

Related to: 10